Name: CVS Health Corp. (NYSE:CVS) | Balance Sheet: Assets
Creator: Stock Analysis on Net

Balance Sheet: Assets

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.

Assets: Selected Items

Download chart

Current Assets: Selected Items

Download chart

CVS Health Corp., consolidated balance sheet: assets

US$ in millions

	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash and cash equivalents	8,586)	8,196)	12,945)	9,408)	7,854)
Investments	2,407)	3,259)	2,778)	3,117)	3,000)
Accounts receivable, net	36,469)	35,227)	27,276)	24,431)	21,742)
Inventories	18,107)	18,025)	19,090)	17,760)	18,496)
Assets held for sale	—)	—)	908)	—)	—)
Other current assets	3,076)	3,151)	2,685)	5,292)	5,277)
Current assets	68,645)	67,858)	65,682)	60,008)	56,369)
Long-term investments	28,934)	23,019)	21,096)	23,025)	20,812)
Property and equipment, net	12,993)	13,183)	12,873)	12,896)	12,606)
Operating lease right-of-use assets	15,944)	17,252)	17,872)	19,122)	20,729)
Goodwill	91,272)	91,272)	78,150)	79,121)	79,552)
Intangible assets, net	27,323)	29,234)	24,754)	29,026)	31,142)
Separate accounts assets	3,311)	3,250)	3,228)	5,087)	4,881)
Other assets	4,793)	4,660)	4,620)	4,714)	4,624)
Long-term assets	184,570)	181,870)	162,593)	172,991)	174,346)
Total assets	253,215)	249,728)	228,275)	232,999)	230,715)

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

Total assets exhibited a general upward trajectory over the five-year period, increasing from US$ 230,715 million in 2020 to US$ 253,215 million in 2024. While there was a moderate contraction in 2022, the subsequent recovery and growth were primarily driven by significant increases in accounts receivable and the recognition of additional goodwill.

Liquidity and Current Asset Trends: Current assets grew steadily from US$ 56,369 million in 2020 to US$ 68,645 million in 2024. This expansion was largely propelled by a substantial rise in net accounts receivable, which increased from US$ 21,742 million to US$ 36,469 million over the period. Cash and cash equivalents experienced volatility, peaking in 2022 at US$ 12,945 million before declining and stabilizing at US$ 8,586 million by the end of 2024. Inventories remained relatively stable, maintaining a range between US$ 17,760 million and US$ 19,090 million.
Intangible Assets and Strategic Growth: A significant portion of the asset base is comprised of goodwill and intangible assets, highlighting a growth strategy focused on acquisitions. Goodwill remained relatively flat until 2023, when it increased sharply from US$ 78,150 million to US$ 91,272 million. Net intangible assets showed a fluctuating pattern, declining from US$ 31,142 million in 2020 to US$ 27,323 million in 2024, despite a temporary increase in 2023.
Fixed Assets and Long-term Investments: Long-term investments showed a marked increase in the final year, rising to US$ 28,934 million in 2024. In contrast, operating lease right-of-use assets followed a consistent downward trend, decreasing from US$ 20,729 million in 2020 to US$ 15,944 million in 2024. Net property and equipment remained nearly stagnant throughout the period, ending 2024 at US$ 12,993 million, suggesting minimal expansion in physical infrastructure.

AI Ask an analyst for more

My previous chats

Add tokens

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.

How can I help you?